文献速递血液净化与透析

肾衰竭患者对下一代肾脏替代治疗的偏好权衡

Patient Preference Trade-offs for Next-Generation Kidney Replacement Therapies.
PubMed 文献 · Clin J Am Soc Nephrol · 2023-10-06

本研究采用基于选择的联合分析离散选择仪器,调查498例肾衰竭患者,评估九项风险与获益属性对治疗选择的影响。结果显示除随访要求外所有属性均显著影响患者选择,患者愿以1%感染风险和0.5%死亡风险换取完全活动自由。

要点

  • 除随访要求外,所有风险与获益属性均显著影响患者选择偏好。
  • 5年内死亡风险每增加1%,偏好效用降低2.22(β=-2.22;95%CI -2.52至-1.91)。
  • 患者愿以1%感染风险和0.5%死亡风险换取完全活动自由并摆脱中心血透。

核心结论

  • 尽管患者厌恶5年内死亡风险、严重感染和永久装置排斥风险各增加1%,但肾衰竭患者表示愿以这些风险换取完全活动自由的获益。

研究设计与样本

  • 开发基于选择的联合分析离散选择仪器,调查498例肾衰竭患者,仪器包含九项风险与获益属性,采用随机全轮廓平衡重叠设计含14个选择对和5个固定任务,使用混合效应回归模型分析。

主要发现

  • 除随访要求外,所有变量对患者选择偏好均显著重要。
  • 5年内死亡风险每增加1%,偏好效用降低2.22(β=-2.22;95%CI -2.52至-1.91)。
  • 严重感染风险每增加1%,效用降低1.38(β=-1.46;95%CI -1.77至-1.00)。
  • 患者愿以1%感染风险和0.5%死亡风险换取完全活动自由并摆脱中心血透(β=1.46;95%CI 1.27至1.64)。

关键数值与推荐

  • 风险属性包括严重感染、5年内死亡、永久装置失败、手术要求、随访要求;获益属性包括更少饮食限制、改善活动能力、药物负担、疲劳。

临床怎么用

  • 医疗设备创新者可利用患者输入来指导产品设计和开发。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Next-generation implantable and wearable KRTs may revolutionize the lives of patients undergoing dialysis by providing more frequent and/or prolonged therapy along with greater mobility compared with in-center hemodialysis. Medical device innovators would benefit from patient input to inform product design and development. Our objective was to determine key risk/benefit considerations for patients with kidney failure and test how these trade-offs could drive patient treatment choices. METHODS: We developed a choice-based conjoint discrete choice instrument and surveyed 498 patients with kidney failure. The choice-based conjoint instrument consisted of nine attributes of risk and benefit pertinent across KRT modalities. Attributes were derived from literature reviews, patient/clinician interviews, and pilot testing. The risk attributes were serious infection, death within 5 years, permanent device failure, surgical requirements, and follow-up requirements. The benefit attributes were fewer diet restrictions, improved mobility, pill burden, and fatigue. We created a random, full-profile, balanced overlap design with 14 choice pairs plus five fixed tasks to test validity. We used a mixed-effects regression model with attribute levels as independent predictor variables and choice decisions as dependent variables. RESULTS: All variables were significantly important to patient choice preferences, except follow-up requirements. For each 1% higher risk of death within 5 years, preference utility was lower by 2.22 ( β =-2.22; 95% confidence interval [CI], -2.52 to -1.91), while for each 1% higher risk of serious infection, utility was lower by 1.38 ( β =-1.46; 95% CI, -1.77 to -1.00) according to comparisons of the β coefficients. Patients were willing to trade a 1% infection risk and 0.5% risk of death to gain complete mobility and freedom from in-center hemodialysis ( β =1.46; 95% CI, 1.27 to 1.64). CONCLUSIONS: Despite an aversion to even a 1% higher risk of death within 5 years, serious infection, and permanent device rejection, patients with kidney failure suggested that they would trade these risks for the benefit of complete mobility.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Wilson L, Gress AF, Frassetto L, et al. Patient Preference Trade-offs for Next-Generation Kidney Replacement Therapies. Clin J Am Soc Nephrol. 2023. PMID: 37874941. doi:10.2215/CJN.0000000000000313

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。